Sio Gene Therapies Revenue and Competitors
Estimated Revenue & Valuation
- Sio Gene Therapies's estimated annual revenue is currently $11.9M per year.
- Sio Gene Therapies's estimated revenue per employee is $126,968
- Sio Gene Therapies's current valuation is $87.1M. (January 2022)
Employee Data
- Sio Gene Therapies has 94 Employees.
Sio Gene Therapies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Associate Director GCP/GLP Quality Assurance | Reveal Email/Phone |
2 | Senior Director Clinical Operations | Reveal Email/Phone |
3 | Manager, IT Operations (Consultant) | Reveal Email/Phone |
4 | Senior Procurement Manager | Reveal Email/Phone |
Sio Gene Therapies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Sio Gene Therapies?
Sio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients. Our current pipeline of clinical-stage candidates includes the first potentially curative AAV-based gene therapies for GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, which are rare and uniformly fatal pediatric conditions caused by single gene deficiencies. We are also expanding the reach of gene therapy to highly prevalent conditions such as Parkinson's disease, which affects millions of patients globally. Led by an experienced team of gene therapy development experts, and supported by collaborations with premier academic, industry and patient advocacy organizations, Sio is focused on accelerating its candidates through clinical trials to liberate patients with debilitating diseases through the transformational power of gene therapies. For more information, visit www.siogtx.com.
keywords:N/A
N/A
Total Funding
94
Number of Employees
$11.9M
Revenue (est)
N/A
Employee Growth %
$87.1M
Valuation
N/A
Accelerator
Sio Gene Therapies News
Zero analysts have provided estimates for Sio Gene Therapies' earnings. The lowest EPS estimate is ($0.24) and the highest is ($0.16).
HC Wainwright dropped their target price on shares of Sio Gene Therapies from $10.00 to $7.00 and set a buy rating on the stock in a report on...
Sio Gene Therapies Inc is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.6M | 94 | -10% | $71.2M |
#2 | $25.4M | 94 | -5% | N/A |
#3 | $19.7M | 94 | 11% | N/A |
#4 | $13.6M | 94 | N/A | N/A |
#5 | $13.6M | 94 | N/A | N/A |